FeesSafety
Pluang+

40 new wallets withdrew 9,458 BTC worth $771.5M from Wintermute since Oct 1, signaling possible whale accumulation.

Market News
24 Oct 2026
Crypto news
View Source
Bullish
40 new wallets withdrew 9,458 BTC worth $771.5M from Wintermute since Oct 1, signaling possible whale accumulation.

Since October 1, 40 newly created wallets have withdrawn 9,458 BTC valued at $771.5 million from Wintermute, suggesting significant Bitcoin whale accumulation. However, these transfers only show movement to new addresses without confirming actual buyers or purchase prices. Market commentators note this activity as smart money buying during market fear, but the data doesn't prove all coins were bought at the implied price of around $81,571 per BTC. Additionally, a separate large inflow of 32,380 BTC in one day was reported, the biggest since April, indicating active whale movements that could influence Bitcoin's price trend.

Bitcoin whale movements are the subject, with Pluang's market snapshot as of Oct 24, 2026 18:51 WIB showing that among 50 major cryptocurrencies priced on Pluang, 6 rose and 43 fell today. Notable price changes include SXP (Solar) down 46.27% to Rp37, BAL (Balancer) up 11.14% to Rp16.297, and DOT (Polkadot) down 9.41% to Rp19.215 with a Pluang order activity split of 48% Sell and 52% Buy. The most notable figure is BAL's 11.14% gain.

More News

Nanobiotix reports promising Phase 1 results for JNJ-1900 in advanced melanoma resistant to anti-PD-1 therapies

Nanobiotix reports promising Phase 1 results for JNJ-1900 in advanced melanoma resistant to anti-PD-1 therapies

Nanobiotix announced positive Phase 1 trial results for JNJ-1900 (NBTXR3), used with radiotherapy and immune checkpoint inhibitors, in 24 heavily pretreated advanced melanoma patients resistant to anti-PD-1 therapies. The treatment showed a 41.7% obj...

Company Fundamentals
Bullish
1 hour ago
Genmab and Incyte launch trial combining petosemtamab and INCB161734 for KRAS G12D metastatic colorectal cancer.

Genmab and Incyte launch trial combining petosemtamab and INCB161734 for KRAS G12D metastatic colorectal cancer.

Genmab and Incyte announced a Phase 1/2 clinical trial to test a combination of petosemtamab, INCB161734, and standard chemotherapy as a first-line treatment for metastatic colorectal cancer with the KRAS G12D mutation. This mutation is common and li...

Company Fundamentals
Bullish
1 hour ago
AirTripMaker launches guide for Business Class flights from the US to 15 global destinations.

AirTripMaker launches guide for Business Class flights from the US to 15 global destinations.

AirTripMaker has introduced a comprehensive Business Class Flight Routes Guide to help travelers from the US explore premium flight options to 15 major international destinations across Asia, Europe, Africa, and Australia. The guide covers airlines, ...

Others
Neutral
3 hours ago
Tether's Mining Development Kit gains support from 15 mining firms to unify Bitcoin mining tools.

Tether's Mining Development Kit gains support from 15 mining firms to unify Bitcoin mining tools.

Tether has announced that 15 mining operators, ASIC manufacturers, and mining pools have committed to integrating with its open-source Mining Development Kit (MDK). The MDK aims to solve compatibility issues in Bitcoin mining by providing a unified f...

Protocol Fundamentals
Bullish
4 hours ago
U.S. Bitcoin ETFs saw $6.4B inflows since August, outpacing corporate buys amid rising producer prices and rate hike bets.

U.S. Bitcoin ETFs saw $6.4B inflows since August, outpacing corporate buys amid rising producer prices and rate hike bets.

Since August, U.S. spot Bitcoin exchange-traded funds (ETFs) have attracted about $6.4 billion in net inflows, significantly more than the roughly $1.5 billion in Bitcoin purchases by corporate treasuries. BlackRock’s IBIT ETF led with around $6 bill...

Market News
Bullish
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App